News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Rami Manochakian/X
Jun 12, 2025, 19:07

Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared on X:

“Hot Off The Press
U.S. FDA approves Taletrectinib for locally advanced or metastatic ROS1+ non-small cell Lung Cancer.
Approval based on TRUST I and II Trials.
– ORR:
85-90% for treatment-naive patients
52-62% or TKI-pretreated patients”

Read the full article.

Taletrectinib

More posts featuring Rami Manochakian on OncoDaily.

cancer FDA Lung cancer North American Neuroendocrine Tumor Society NSCLC OncoDaily Oncology Rami Manochakian Taletrectinib trust TRUST trial U.S. FDA
Special Coverage
Blog
Jul 23, 2025, 13:27
Joshua Brody: Register for the 9th Live Medical Crossfire - Hematologic Malignancies
Blog
Jul 23, 2025, 13:09
Miriam Mutebi: What Does it Really Mean to Build a Research Career in Africa?
Blog
Jul 23, 2025, 12:05
Tian Zhang: Thank You for Organizing and Inviting Us to ANZUP25
Blog
Jul 23, 2025, 11:34
Paolo Tarantino: Combining ADCs - The Future is Now
Blog
Jul 23, 2025, 11:16
Bishal Gyawali: I Enjoyed Preparing for and Giving This Talk
Blog
Jul 23, 2025, 10:45
Aren Karapetyan Thanks for the Opportunity to Moderate a Session at the ESO – OncoDaily Educational Workshop
Career
Jul 23, 2025, 10:40
Shushan Hovsepyan Is SIOP's 2025 Rising Star Award Recipient Winner
Blog
Jul 23, 2025, 10:30
Rethinking Dose Optimization: Aligning with FDA’s Project Optimus - IQVIA Research and Development Solutions
Blog
Jul 23, 2025, 10:25
Matthew Zachary: The Society for Integrative Oncology Gets It
Blog
Jul 23, 2025, 10:25
Vincent Rajkumar: Approach to Newly Diagnosed Myeloma Has Become Streamlined
Blog
Jul 23, 2025, 10:15
Advancing Osteosarcoma Research to Protect Future Generations - Children's Cancer Institute
Drugs
Jul 23, 2025, 10:05
Linvoseltamab (Lynozyfic) Approved for Myeloma: Key 2025 Updates for Patients